We are live on ! Find out more
HP

HealthInvest Partners Portfolio holdings

AUM $372M
1-Year Est. Return 59.89%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106M
AUM Growth
-$20M
Cap. Flow
-$23.4M
Cap. Flow %
-22.13%
Top 10 Hldgs %
100%
Holding
15
New
–
Increased
8
Reduced
1
Closed
6

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$3.86M
2
CI icon
Cigna
CI
+$3.75M
3
MCK icon
McKesson
MCK
+$3.67M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.56M
5
BMY icon
Bristol-Myers Squibb
BMY
+$3.06M

Top Sells

Rank Stock Value
1
CHRS icon
Coherus Oncology
CHRS
+$9.64M
2
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$7.82M
3
UTHR icon
United Therapeutics
UTHR
+$7.69M
4
UHS icon
Universal Health Services
UHS
+$7.2M
5
COR icon
Cencora
COR
+$6.49M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRWD icon
1
Ironwood Pharmaceuticals
IRWD
$734M
$19.6M 18.54%
1,520,000
+70,000
+5% +$801K
SUPN icon
2
Supernus Pharmaceuticals
SUPN
$2.62B
$16.3M 15.46%
530,000
-4,000
-0.7% -$123K
VRTX icon
3
Vertex Pharmaceuticals
VRTX
$119B
$10.5M 9.94%
52,000
+17,000
+49% +$3.56M
ARAY icon
4
Accuray
ARAY
$32M
$10.4M 9.85%
2,300,000
+325,000
+16% +$1.52M
MCK icon
5
McKesson
MCK
$99B
$9.94M 9.42%
52,000
+19,000
+58% +$3.67M
BMY icon
6
Bristol-Myers Squibb
BMY
$133B
$9.82M 9.31%
147,000
+47,000
+47% +$3.06M
CI icon
7
Cigna
CI
$74.5B
$9.72M 9.21%
41,000
+15,000
+58% +$3.75M
CAH icon
8
Cardinal Health
CAH
$54.8B
$9.71M 9.2%
170,000
+66,000
+63% +$3.86M
ABBV icon
9
AbbVie
ABBV
$435B
$9.57M 9.07%
85,000
+16,000
+23% +$1.8M
CHRS icon
10
Coherus Oncology
CHRS
$224M
– –
-660,000
Closed -$9.64M
COR icon
11
Cencora
COR
$60.1B
– –
-55,000
Closed -$6.49M
CVS icon
12
CVS Health
CVS
$134B
– –
-85,000
Closed -$6.39M
UHS icon
13
Universal Health Services
UHS
$10.3B
– –
-54,000
Closed -$7.2M
UTHR icon
14
United Therapeutics
UTHR
$25.7B
– –
-46,000
Closed -$7.69M
BDSI
15
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-2,000,000
Closed -$7.82M

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
PC
Prevatt Capital Nassau, Bahamas $371M AUM 9.39% 1-Year Est. Return

HealthInvest Partners's Q2 2021 Portfolio in Review

As of Q2 2021, HealthInvest Partners held 15 positions worth $106M, down 16% from $126M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

HealthInvest Partners withdrew a net $23.4M in Q2 2021, closing 6 positions and reducing 1 holding. Its most notable exit was Coherus Oncology, an estimated $9.64M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, HealthInvest Partners added an estimated $3.86M to Cardinal Health.

  • HealthInvest Partners added most to Cardinal Health in Q2 2021, an estimated $3.86M increase.
  • HealthInvest Partners's biggest Q2 2021 reduction was Supernus Pharmaceuticals, cutting an estimated $123K.
  • HealthInvest Partners fully exited Coherus Oncology in Q2 2021, selling an estimated $9.64M.
  • HealthInvest Partners's ten largest holdings make up 100% of its $106M portfolio in Q2 2021.
  • HealthInvest Partners opened 0 new positions and closed 6 in Q2 2021.
  • HealthInvest Partners's portfolio value fell 16% quarter-over-quarter to $106M.

Based on HealthInvest Partners's 13F filing for Q2 2021, filed 10 Aug 2021.